| Epithelial-mesenchymal transition in cancer: parallels between normal development and tumor progression DS Micalizzi, SM Farabaugh, HL Ford Journal of mammary gland biology and neoplasia 15, 117-134, 2010 | 1397 | 2010 |
| A conduit to metastasis: circulating tumor cell biology DS Micalizzi, S Maheswaran, DA Haber Genes & development 31 (18), 1827-1840, 2017 | 479 | 2017 |
| The miR-106b-25 cluster targets Smad7, activates TGF-β signaling, and induces EMT and tumor initiating cell characteristics downstream of Six1 in human breast cancer AL Smith, R Iwanaga, DJ Drasin, DS Micalizzi, RL Vartuli, AC Tan, ... Oncogene 31 (50), 5162-5171, 2012 | 369 | 2012 |
| Deregulation of ribosomal protein expression and translation promotes breast cancer metastasis RY Ebright, S Lee, BS Wittner, KL Niederhoffer, BT Nicholson, A Bardia, ... Science 367 (6485), 1468-1473, 2020 | 316 | 2020 |
| The Six1 homeoprotein induces human mammary carcinoma cells to undergo epithelial-mesenchymal transition and metastasis in mice through increasing TGF-β signaling DS Micalizzi, KL Christensen, P Jedlicka, RD Coletta, AE Barón, ... The Journal of clinical investigation 119 (9), 2678-2690, 2009 | 286 | 2009 |
| Epithelial–mesenchymal transition in development and cancer DS Micalizzi, HL Ford Future oncology 5 (8), 1129-1143, 2009 | 183 | 2009 |
| Eya2 is required to mediate the pro-metastatic functions of Six1 via the induction of TGF-β signaling, epithelial–mesenchymal transition, and cancer stem cell properties SM Farabaugh, DS Micalizzi, P Jedlicka, R Zhao, HL Ford Oncogene 31 (5), 552-562, 2012 | 161 | 2012 |
| SIX1 induces lymphangiogenesis and metastasis via upregulation of VEGF-C in mouse models of breast cancer CA Wang, P Jedlicka, AN Patrick, DS Micalizzi, KC Lemmer, E Deitsch, ... The Journal of clinical investigation 122 (5), 1895-1906, 2012 | 155 | 2012 |
| Six1 overexpression in mammary cells induces genomic instability and is sufficient for malignant transformation RD Coletta, KL Christensen, DS Micalizzi, P Jedlicka, M Varella-Garcia, ... Cancer research 68 (7), 2204-2213, 2008 | 130 | 2008 |
| Homeoprotein Six1 increases TGF-β type I receptor and converts TGF-β signaling from suppressive to supportive for tumor growth DS Micalizzi, CA Wang, SM Farabaugh, WP Schiemann, HL Ford Cancer research 70 (24), 10371-10380, 2010 | 129 | 2010 |
| Expression of Six1 in luminal breast cancers predicts poor prognosis and promotes increases in tumor initiating cells by activation of extracellular signal-regulated kinase and … R Iwanaga, CA Wang, DS Micalizzi, JC Harrell, P Jedlicka, CA Sartorius, ... Breast Cancer Research 14, 1-14, 2012 | 113 | 2012 |
| HIF1A signaling selectively supports proliferation of breast cancer in the brain RY Ebright, MA Zachariah, DS Micalizzi, BS Wittner, KL Niederhoffer, ... Nature communications 11 (1), 6311, 2020 | 82 | 2020 |
| Cancer metastasis through the prism of epithelial‐to‐mesenchymal transition in circulating tumor cells DS Micalizzi, DA Haber, S Maheswaran Molecular oncology 11 (7), 770-780, 2017 | 80 | 2017 |
| Translational regulation of cancer metastasis DS Micalizzi, RY Ebright, DA Haber, S Maheswaran Cancer research 81 (3), 517-524, 2021 | 35 | 2021 |
| A post-transcriptional program of chemoresistance by AU-rich elements and TTP in quiescent leukemic cells S Lee, D Micalizzi, SS Truesdell, SIA Bukhari, M Boukhali, ... Genome biology 21, 1-23, 2020 | 28 | 2020 |
| Phase Ib trial to evaluate safety and anti-tumor activity of the AKT inhibitor, ipatasertib, in combination with endocrine therapy and a CDK4/6 inhibitor for patients with … SA Wander, D Juric, JG Supko, DS Micalizzi, L Spring, N Vidula, M Beeler, ... Journal of Clinical Oncology 38 (15_suppl), 1066-1066, 2020 | 20 | 2020 |
| Identification of Somatically Acquired BRCA1/2 Mutations by cfDNA Analysis in Patients with Metastatic Breast Cancer N Vidula, T Dubash, MS Lawrence, A Simoneau, A Niemierko, E Blouch, ... Clinical Cancer Research 26 (18), 4852-4862, 2020 | 17 | 2020 |
| A Gene Panel Associated With Abemaciclib Utility in ESR1-Mutated Breast Cancer After Prior Cyclin-Dependent Kinase 4/6-Inhibitor Progression JO Brett, TD Dubash, GN Johnson, A Niemierko, V Mariotti, LSL Kim, J Xi, ... JCO Precision Oncology 7, e2200532, 2023 | 12 | 2023 |
| Targeting breast and pancreatic cancer metastasis using a dual-cadherin antibody DS Micalizzi, D Che, BT Nicholson, JF Edd, N Desai, ER Lang, M Toner, ... Proceedings of the National Academy of Sciences 119 (43), e2209563119, 2022 | 11 | 2022 |
| On the trail of invasive cells in breast cancer DS Micalizzi, S Maheswaran Nature 554 (7692), 308-309, 2018 | 10 | 2018 |
